Back

Medscape, LLC

  • Hematologic Neoplasms
  • Multiple Myeloma

18th Annual Hematologic Malignancies Demystified, Session II

The goal of this activity is for learners to be better able to define recent clinical advancements across myeloma, lymphoma, and benign hematologic disorders and integrate these into practice to optimize patient outcomes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 2.5 creditsNursingUp to 2.5 creditsPharmacyUp to 2.5 credits

MOC types

ABIM — Medical KnowledgeUp to 2.5 points

FDA REMS

No

Qualifies for MIPS

No

Faculty 2

All faculty

Pricing

Paid · fee on provider site

See fees on medscape.org

Listed by the provider

  • Enduring / On-demand
  • Credit · Up to 2.5 credits
  • MOC · Up to 2.5 points
  • Paid · fee on provider site
  • Commercial Support
  • Released
    Feb 27, 2026
  • Last day to claim credit
    Mar 3, 2027 5 months left